Role of Mitochondrial-derived Oxidative Stress to Promote Vascular Endothelial Dysfunction in Non-exercisers With Aging
Completed · Not applicable · Has a placebo group
Conditions studied: Aging, Endothelial Dysfunction, Cardiovascular Function, Arterial Stiffness
In brief
The primary goal of this intervention is to determine the efficacy of acute mitochondrial-specific antioxidants to improve vascular endothelial function in middle-aged and older (≥45 y) adults who do no perform regular aerobic exercise. In a double-blind, randomized, placebo-controlled crossover design participants with receive both MitoQ and placebo arm of the study. Primary endpoints will include vascular endothelial function assessed by brachial artery flow-mediated dilation and cardiac function assessed via pulse wave analysis. Secondary endpoints will include measures of aortic stiffness assessed by carotid-femoral pulse wave velocity and carotid artery stiffness (e.g. β-stiffness) and elasticity (carotid compliance, distensibility, and Youngs elastic modulus) from ultrasonography.
Key facts
- Study ID
- NCT05872139
- Run by
- Ball State University
- People needed
- 23
- Starts
- 2022-09-23
- Expected to finish
- 2023-05-01
- Last updated by the study team
- 2023-05-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Resting brachial blood pressure <160 mmHg (systolic)/<100 mmHg (diastolic)
- Body mass index ≤ 35 kg/m2
- Nonsmoker
- Women must be postmenopausal defined as cessation of menses ≥ 1 year.
You may not qualify if…
- cardiovascular/metabolic medications
- known clinical disease
- absolute contraindications to exercise testing
Where it is running
- Ball State University — Muncie, Indiana, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.